Catalogo dei prodotti della ricerca

D'ASCENZIO, MELISSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 742
EU - Europa 188
AS - Asia 70
AF - Africa 6
SA - Sud America 3
Totale 1.009
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 739
IT - Italia 86
IN - India 37
DE - Germania 28
CN - Cina 22
SE - Svezia 21
GB - Regno Unito 20
FI - Finlandia 18
UA - Ucraina 7
SG - Singapore 6
TG - Togo 4
AR - Argentina 3
CA - Canada 3
TR - Turchia 3
ES - Italia 2
IE - Irlanda 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
BG - Bulgaria 1
FR - Francia 1
Totale 1.009
Salva come PNG Salva come JPEG
Città #
Fairfield 144
Woodbridge 80
Ashburn 72
Seattle 60
Cambridge 51
Wilmington 50
Houston 46
Rome 29
Chandler 21
Ann Arbor 17
Dearborn 17
Princeton 17
New York 16
Plano 15
San Paolo di Civitate 14
Latina Scalo 12
Lawrence 12
San Diego 11
Beijing 10
Grafing 9
Millbury 9
Boston 7
Cagliari 6
Helsinki 5
Norwalk 5
Lomé 4
Andover 3
Bremen 3
Federal 3
Hefei 3
Jacksonville 3
Singapore 3
Bursa 2
Chieti 2
Delhi 2
Des Moines 2
Dimāpur 2
Dublin 2
Falls Church 2
Fasano 2
Fonte Nuova 2
Laurel 2
Meknes 2
Redwood City 2
Salamanca 2
Simi Valley 2
Aizawl 1
Berlin 1
Bolzano Vicentino 1
Campobello Di Mazara 1
Changchun 1
Fulham 1
Guangzhou 1
Huzhou 1
Indiana 1
Istanbul 1
Janesville 1
Kuching 1
Kunming 1
Las Vegas 1
Massimeno 1
Montréal 1
Munich 1
Ottawa 1
Pontinia 1
Provo 1
Shanghai 1
Shenyang 1
Sofia 1
Southend 1
Taramani 1
Toronto 1
Washington 1
Wuhan 1
Totale 813
Salva come PNG Salva come JPEG
Nome #
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity 107
Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma 92
Recent advances in the development of selective human MAO-B inhibitors: (Hetero)arylidene-(4-substituted-thiazol-2- yl)hydrazines 86
4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis 82
Synthesis and selective inhibition of human monoamine oxidases of a large scaffold of (4,5-substituted-thiazol-2-yl)hydrazones 80
Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii 78
Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors 70
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 69
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII—A new scaffold for designing isoform-selective inhibitors 67
Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives 59
Selective MAO-B inhibitors: a lesson from natural products 56
null 54
Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential 53
null 50
Synthesis and biological evaluation of new potential co-adjuvants for the treatment of Parkinson’s disease and a new catalytic, asymmetric approach to the synthesis of fused heterocycles of biological interest. 37
Opening new scenarios for human MAO inhibitors 10
New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies 9
Totale 1.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019108 0 0 0 0 0 0 0 0 0 0 67 41
2019/2020315 34 11 0 15 27 39 49 40 47 28 15 10
2020/2021101 8 11 9 3 0 10 0 9 26 18 6 1
2021/2022173 1 13 20 2 19 5 9 14 11 11 38 30
2022/2023136 33 32 1 11 11 12 2 8 15 1 10 0
2023/202494 5 13 5 6 8 35 0 15 1 6 0 0
Totale 1.059